Filter
315
Text search:
pfizer
Featured
Recommendations
41
New Publications
17
Language
Document type
No document type
79
Guidelines
73
Studies & Reports
64
Fact sheets
41
Manuals
16
Strategic & Response Plan
15
Resource Platforms
8
Situation Updates
5
Training Material
4
Videos
4
Infographics
3
Online Courses
3
Countries / Regions
Brazil
14
Russia
11
Germany
9
Argentina
9
Global
9
South Africa
8
Ukraine
7
Middle East and North Africa
7
Latin America and the Carribbean
7
Mozambique
6
India
5
Chile
5
Africa
5
Ecuador
4
Senegal
3
China
3
Colombia
3
East and Southern Africa
3
West and Central Africa
3
Western and Central Europe
3
Paraguay
3
Liberia
2
Nigeria
2
Uganda
2
Philippines
2
Kenya
2
Indonesia
2
Peru
2
El Salvador
2
Congo, Democratic Republic of
1
Guinea-Bissau
1
Ghana
1
Somalia
1
Nepal
1
South Sudan
1
Syria
1
Chad
1
Tanzania
1
Sudan
1
Benin
1
Angola
1
Yemen
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Eastern Europe
1
Congo-Brazzaville
1
Timor Leste/ East Timor
1
Iran
1
Kazakhstan
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
104
Clinical Guidelines
20
Women & Child Health
7
Public Health
6
Key Resources
4
Annual Report MEDBOX
1
Pharmacy & Technologies
1
Toolboxes
COVID-19
154
Mental Health
30
TB
16
HIV
15
NTDs
14
AMR
12
Refugee
8
NCDs
8
Global Health Education
6
Disability
4
Health Financing Toolbox
4
Rapid Response
3
Caregiver
3
Pharmacy
3
Ebola
1
Conflict
1
Zika
1
Planetary Health
1
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s
...
WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses
Situation Analaysis and Needs Assessment
WHO Guideline. Since 2010, countries in the meningitis belt have started to introduce a new serogroup A meningococcal conjugate vaccine conferring individual protection and herd immunity. Following the successful roll-out of this vaccine, epidemics due to Neisseria meningitidis serogroup A (NmA) are
...
PLOS Neglected Tropical Diseases September 2014 | Volume 8 | Issue 9 | e3016 DOI: 10.1371/journal.pntd.0003016
This guideline provides health policy-makers and decision-makers in health professional training institutions with advice on the rationale for health-care providers’ use of counselling skills to address sexual health concerns in a primary health care setting
3 March 2016
Irresponsible pharmaceutical companies fuel the proliferation of superbugs through supply chain pollution, the European Public Health Alliance (EPHA) reports. The advocacy group uncovered lapses such as dirty production and inadequate waste disposal in the production of antimicrobials in China and I
...
Prices people pay for medicines.
These WHO guidelines which were updated in 2018, are valid for any country and suitable to local adaptations, and take account of the strength of available scientific evidence, the cost and resource implications, and patient values and preferences.
The 2018 edition of the guidelines includes the re
...
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
Lancet Planet Health 2017 Published Online November 6, 2017 http://dx.doi.org/10.1016/S2542-5196(17)30141-9
